News

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

July 27, 2022

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.

Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test

July 27, 2022

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.

WuXi STA Opens a New Large-Scale Continuous Manufacturing Plant

July 27, 2022

WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.

FDA Continues to Grapple with Accelerated Approval Issues

July 26, 2022

Scrutiny of accelerated approvals has generated a range of reform proposals to accelerate the conduct of confirmatory studies.

Discovery Life Sciences Acquires AllCells

July 26, 2022

Discovery Life Sciences’ acquisition of AllCells is intended to bolster its cell and gene therapy products and services.

AstraZeneca to Acquire TeneoTwo in Deal Worth Up to $1.26 Billion

July 26, 2022

AstraZeneca's acquisition of TeneoTwo will give the company access to its clinical-stage T-cell engager, TNB-486, strengthening their hematological cancer pipeline.

WHO Declares Monkeypox Spread a Global Health Emergency

July 25, 2022

WHO has determined that monkeypox constitutes a public health emergency of international concern.

Merck and Orion Announce Global Collaboration for Oncology Drug

July 25, 2022

Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.

EMA Recommends Eleven New Medicines

July 25, 2022

The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.

EMA Endorses Statement on International Collaboration of Real-World Evidence

July 25, 2022

A joint statement calling for international collaboration on the creation and use of real-world evidence has been published by the International Coalition of Medicines Regulatory Authorities.